Who invested in T3D Therapeutics?
T3D Therapeutics's investors include National Institute on Aging and National Institute on Aging.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$24Mraised across 6 rounds since 2013, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $6.0M sold, first sale Aug 2022
Reported by FinSMEsSEC filing: $15M sold, first sale Oct 2019
No investor was named in the report.
From a historical funding recordSEC filing: $115K sold, first sale Feb 2015
No investor was named in the report.
From a historical funding recordSEC filing: $115K sold, first sale Feb 2015
No investor was named in the report.
From a historical funding recordSEC filing: $661K sold, first sale Mar 2014
No investor was named in the report.
Reported by sec.govSEC filing: $437K sold, first sale Jun 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
T3D Therapeutics's investors include National Institute on Aging and National Institute on Aging.
T3D Therapeutics has raised $24M across 6 rounds since 2013.
T3D Therapeutics's most recent round was a Venture of $6.0M in Sept 2022.
T3D Therapeutics's largest round on record is $15M (Undisclosed round), in Nov 2019.
T3D Therapeutics's first round on record, in Nov 2019, was backed by National Institute on Aging.
T3D Therapeutics's latest named round is a Venture, in Sept 2022.
T3D Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.